PFLotus catheter with mapping system for persistent atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests a new catheter (PFLotus) with a special mapping system to help treat people with persistent atrial fibrillation (a long-lasting irregular heartbeat). The goal is to see if it can safely and effectively restore a normal heart rhythm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days or has been diagnosed as persistent), and it causes symptoms.
- You have tried at least one heart rhythm medication (like flecainide or amiodarone) and it didn't control your rhythm or you couldn't take it.
- You have not had a prior ablation (a procedure to burn or freeze heart tissue) for atrial fibrillation, and you don't have a pacemaker or defibrillator.
- You have not had a heart attack, stent, or heart surgery in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called PFLotus for people with persistent atrial fibrillation (AF), a type of irregular heartbeat. The goal is to see if it can help restore a normal heart rhythm in people who haven't gotten better with medicine.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This trial tests a more precise way to burn (ablate) the back wall of the left upper heart chamber during the first ablation for persistent atrial fibrillation (AF). It aims to improve heart rhythm control and reduce the chance of AF coming back.
This trial tests a new method to treat persistent atrial fibrillation (a long-lasting irregular heartbeat) to see if it helps patients who haven't been helped by medication. It focuses on cleaning up the back wall of the heart to restore a normal rhythm.
Hear when a new Persistent Atrial Fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.